Meeting
2018 ASCO-SITC Clinical Immuno-Oncology Symposium
Immunological impact of ramucirumab on tumor microenvironment in advanced gastric cancer.
Authors
Yosuke Togashi
National Cancer Center Hospital East, Kashiwa, Japan
Yosuke Togashi, Yasuko Tada, Daisuke Kotani, Akihito Kawazoe, Toshihiko Doi, Hiroyoshi Nishikawa, Kohei Shitara
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Developmental Therapeutics,Genitourinary Cancer,Head and Neck Cancer,Lung Cancer,Melanoma/Skin Cancers,Gastrointestinal Cancer,Breast and Gynecologic Cancers,Combination Studies,Implications for Patients and Society,Miscellaneous Cancers,Oncolytic Viruses,Hematologic Malignancies
Sub Track
Immune Checkpoints and Stimulatory Receptors
Citation
J Clin Oncol 36, 2018 (suppl 5S; abstr 98)
DOI
10.1200/JCO.2018.36.5_suppl.98
Abstract #
98
Poster Bd #
F7
Abstract Disclosures
Similar Posters
Poster
2019 Gastrointestinal Cancers Symposium
Activation of central/effector memory T cells in advanced gastric cancer patients treated with antiprogrammed death-1 antibody.
First Author: Hirofumi Ohmura
Poster
2018 ASCO Annual Meeting
Immune profiling in a randomized phase II trial of acalabrutinib and pembrolizumab (PA) versus pembrolizumab (P) for patients with metastatic urothelial cancer (mUC).
First Author: Tian Zhang
Poster
2017 ASCO-SITC Clinical Immuno-Oncology Symposium
Immune profiling of circulating T cells and TILs following neoadjuvant ipilimumab and chemotherapy in non-small cell lung cancer (NSCLC).
First Author: John Yi
Poster
2024 ASCO Genitourinary Cancers Symposium
Preclinical testing of a novel PD-L1 inhibitor for the treatment of renal cell carcinoma.
First Author: Michelle Hsu